• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维板层型肝细胞癌中的冷凝集素病:一种与罕见癌症变体的罕见关联。

Cold agglutinin disease in fibrolamellar hepatocellular carcinoma: a rare association with a rare cancer variant.

作者信息

Al-Matham Khalid, Alabed Iehab, Zaidi Syed Z A, Qushmaq Khalid A

机构信息

Department of Internal Medicine, Main Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.

出版信息

Ann Saudi Med. 2011 Mar-Apr;31(2):197-200. doi: 10.4103/0256-4947.76409.

DOI:10.4103/0256-4947.76409
PMID:21293066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3102484/
Abstract

Cold agglutinin disease (CAD) is a rare autoimmune hemolytic anemia. Although it can occur secondary to lymphoproliferative disorders and autoimmune or infectious diseases, CAD is rarely reported as secondary to solid tumors. We report a case of a woman aged 18 years diagnosed with a well-differentiated hepatocellular carcinoma of the fibrolamellar subtype, who was shown to have CAD also. Her general condition, including CAD, improved after targeted therapy with sorafenib for the hepatocellular carcinoma and only conservative measures for the CAD that consisted of avoidance of cold. In summary, although it is an extremely rare association and less common than lymphoproliferative disorders, CAD can be associated with solid tumors.

摘要

冷凝集素病(CAD)是一种罕见的自身免疫性溶血性贫血。尽管它可继发于淋巴增殖性疾病、自身免疫性疾病或感染性疾病,但很少有CAD继发于实体瘤的报道。我们报告一例18岁女性,诊断为纤维板层型高分化肝细胞癌,同时也患有CAD。在针对肝细胞癌使用索拉非尼进行靶向治疗以及仅对CAD采取包括避免受寒在内的保守措施后,她的总体状况,包括CAD,有所改善。总之,尽管CAD与实体瘤的关联极为罕见,且不如与淋巴增殖性疾病的关联常见,但CAD可与实体瘤相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d50a/3102484/84ed0d7b2130/ASM-31-197-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d50a/3102484/13934dd4d0ff/ASM-31-197-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d50a/3102484/f107388b1d52/ASM-31-197-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d50a/3102484/d9165ae5b8cb/ASM-31-197-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d50a/3102484/84ed0d7b2130/ASM-31-197-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d50a/3102484/13934dd4d0ff/ASM-31-197-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d50a/3102484/f107388b1d52/ASM-31-197-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d50a/3102484/d9165ae5b8cb/ASM-31-197-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d50a/3102484/84ed0d7b2130/ASM-31-197-g004.jpg

相似文献

1
Cold agglutinin disease in fibrolamellar hepatocellular carcinoma: a rare association with a rare cancer variant.纤维板层型肝细胞癌中的冷凝集素病:一种与罕见癌症变体的罕见关联。
Ann Saudi Med. 2011 Mar-Apr;31(2):197-200. doi: 10.4103/0256-4947.76409.
2
Fatal hemobilia in advanced hepatocellular carcinoma invading biliary tract after treatment with sorafenib and biliary stenting.索拉非尼和胆道支架置入治疗后,晚期肝细胞癌侵犯胆道导致致命性胆道出血。
Ann Oncol. 2010 Jun;21(6):1381-1382. doi: 10.1093/annonc/mdq071. Epub 2010 Mar 23.
3
Commentary: Sorafenib use in patients with advanced hepatocellular carcinoma and underlying Child-Pugh B cirrhosis: evidence and controversy.评论:索拉非尼在晚期肝细胞癌合并Child-Pugh B级肝硬化患者中的应用:证据与争议
Oncologist. 2009 Jan;14(1):67-9. doi: 10.1634/theoncologist.2008-0281. Epub 2009 Jan 15.
4
Sorafenib use in hepatocellular carcinoma in Japan: early experience and impact on clinical practice.索拉非尼在日本肝细胞癌治疗中的应用:早期经验及对临床实践的影响。
Clin Drug Investig. 2012 Aug 8;32 Suppl 2:1-2. doi: 10.1007/BF03265491.
5
Sorafenib in hepatocellular carcinoma.索拉非尼用于肝细胞癌的治疗。
Br J Hosp Med (Lond). 2010 Aug;71(8):451-6. doi: 10.12968/hmed.2010.71.8.77669.
6
Target therapy for hepatocellular carcinoma: is sorafenib for everybody?肝细胞癌的靶向治疗:索拉非尼适用于所有人吗?
J Clin Gastroenterol. 2009 May-Jun;43(5):389-90. doi: 10.1097/MCG.0b013e31819eb9a6.
7
Hepatocellular carcinoma: sorafenib before liver transplantation?肝细胞癌:肝移植前使用索拉非尼?
Hepatology. 2010 Jun;51(6):2232-3. doi: 10.1002/hep.23439.
8
Sorafenib, a systemic therapy for hepatocellular carcinoma.索拉非尼,一种用于治疗肝细胞癌的全身治疗药物。
Ann Hepatol. 2008 Jan-Mar;7(1):46-51.
9
[Recommendations for the management of Sorafenib in patients with hepatocellular carcinoma].[索拉非尼治疗肝细胞癌患者的管理建议]
Gastroenterol Hepatol. 2010 Dec;33(10):741-52. doi: 10.1016/j.gastrohep.2010.05.007. Epub 2010 Sep 18.
10
Impressive efficacy of sorafenib in a patient with an hepatocellular carcinoma and a portal vein thrombosis associated with a metastatic ENT cancer.索拉非尼治疗伴有转移性头颈部肿瘤的肝细胞癌和门静脉癌栓患者的显著疗效。
Med Oncol. 2011 Dec;28 Suppl 1:S246-9. doi: 10.1007/s12032-010-9708-8. Epub 2010 Oct 9.

引用本文的文献

1
Cold Agglutinin Syndrome as the Initial Presentation of Acute Myeloid Leukemia: A Case Report.冷凝集素综合征作为急性髓系白血病的首发表现:一例报告
Clin Case Rep. 2025 Sep 29;13(10):e71061. doi: 10.1002/ccr3.71061. eCollection 2025 Oct.
2
Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy.冷抗体自身免疫性溶血性贫血:其与肿瘤性疾病的关联及其对治疗的影响。
Curr Oncol Rep. 2024 Sep;26(9):1085-1096. doi: 10.1007/s11912-024-01569-8. Epub 2024 Jun 14.
3
Case Report of Fibrolamellar Hepatocellular Carcinoma in A 15-Year-old Male.

本文引用的文献

1
Cold antibody autoimmune hemolytic anemias.冷抗体型自身免疫性溶血性贫血
Blood Rev. 2008 Jan;22(1):1-15. doi: 10.1016/j.blre.2007.08.002. Epub 2007 Sep 27.
2
Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.原发性慢性冷凝集素病:发病机制、临床特征及治疗的最新进展
Hematology. 2007 Oct;12(5):361-70. doi: 10.1080/10245330701445392.
3
Hepatocellular carcinoma with chronic B-type hepatitis complicated by autoimmune hemolytic anemia: a case report.慢性乙型肝炎合并自身免疫性溶血性贫血的肝细胞癌:一例报告
15 岁男性肝纤维板层肝细胞癌 1 例报告
Med Arch. 2022 Oct;76(5):387-390. doi: 10.5455/medarh.2022.76.387-390.
4
Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event.纤维板层型肝细胞癌:一种罕见但不良的病症。
World J Gastrointest Oncol. 2022 Jun 15;14(6):1103-1114. doi: 10.4251/wjgo.v14.i6.1103.
5
Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.纤维板层肝细胞癌的临床特征和手术治疗效果:单中心回顾性分析。
World J Surg Oncol. 2020 May 12;18(1):93. doi: 10.1186/s12957-020-01855-2.
6
Cold autoimmune hemolytic anemia: a rare association with triple-positive breast cancer.冷凝集素型自身免疫性溶血性贫血:一种与三阳性乳腺癌的罕见关联。
J Community Hosp Intern Med Perspect. 2019 Dec 14;9(6):499-502. doi: 10.1080/20009666.2019.1698262. eCollection 2019.
7
Pembrolizumab-associated autoimmune haemolytic anaemia.帕博利珠单抗相关的自身免疫性溶血性贫血。
BMJ Case Rep. 2019 Oct 25;12(10):e229064. doi: 10.1136/bcr-2018-229064.
8
Fibrolamellar hepatocellular carcinoma: current clinical perspectives.纤维板层肝细胞癌:当前的临床观点。
J Hepatocell Carcinoma. 2015 Oct 9;2:151-7. doi: 10.2147/JHC.S75153. eCollection 2015.
9
An unusual presentation of metastatic breast carcinoma as cold autoimmune hemolytic anemia.转移性乳腺癌表现为冷凝集素型自身免疫性溶血性贫血的罕见病例。
Turk J Haematol. 2015 Mar 5;32(1):85-6. doi: 10.4274/tjh.2014.0373.
10
Fibrolamellar carcinoma: 2012 update.纤维板层癌:2012年更新
Scientifica (Cairo). 2012;2012:743790. doi: 10.6064/2012/743790. Epub 2012 Sep 23.
World J Gastroenterol. 2007 Aug 28;13(32):4401-4. doi: 10.3748/wjg.v13.i32.4401.
4
Management of cold haemolytic syndrome.冷凝集素综合征的管理
Br J Haematol. 2007 Aug;138(4):422-9. doi: 10.1111/j.1365-2141.2007.06664.x. Epub 2007 Jun 11.
5
Review of the clinicopathologic features of fibrolamellar carcinoma.纤维板层癌的临床病理特征综述。
Adv Anat Pathol. 2007 May;14(3):217-23. doi: 10.1097/PAP.0b013e3180504913.
6
Major colorectal surgery in a patient with cold agglutinin disease.患有冷凝集素病患者的大肠大手术。
Anaesthesia. 2006 Jun;61(6):593-6. doi: 10.1111/j.1365-2044.2006.04650.x.
7
Primary chronic cold agglutinin disease: a population based clinical study of 86 patients.原发性慢性冷凝集素病:一项基于86例患者的人群临床研究。
Haematologica. 2006 Apr;91(4):460-6.
8
Cold agglutinin disease.
Haematologica. 2006 Apr;91(4):439-41.
9
Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma.与青年纤维板层型肝癌患者生存相关的临床和病理因素。
BMC Cancer. 2005 Oct 31;5:142. doi: 10.1186/1471-2407-5-142.
10
Immune-mediated hemolytic anemia.免疫介导的溶血性贫血
Hematology Am Soc Hematol Educ Program. 2004:48-62. doi: 10.1182/asheducation-2004.1.48.